Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobials or antibacterial. After the discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Market Overview and Dynamics
The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 million by 2027 from US$ 11,591.97 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases and consolidated government initiatives in emerging economies. However, the tedious and expensive process associated with antibiotic development and impact of COVID-19 pandemic is likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the Asia Pacificantibiotics market in 2019. In terms of action mechanism, the cell wall synthesis inhibitors segment is expected to hold the largest share of the antibiotics market by 2027..
Major Sources and Companies Listed
Some of the major primary and secondary sources for Antibioticsmarket included in the report are, World Health Organization (WHO), Central Drugs Standard Control Organisation (CDSCO), Center for Disease Dynamics, Economics & Policy (CDDEP), and others.
Reasons to buy the report
- To understand the antibiotics market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Antibiotics market
- Efficiently plan M&A and partnership dealsin antibiotics market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Antibiotics market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region.
ASIA PACIFICANTIBIOTICSMARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Geography
-
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Astellas Pharma Inc
- Pfizer Inc
Asia Pacific Antibiotics Market Strategic Insights
Asia Pacific Antibiotics Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 11,591.97 Million |
| Market Size by 2027 | US$ 15,784.01 Million |
| CAGR (2020 - 2027) | 4.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Class
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
Asia Pacific Antibiotics Market Country and Regional Insights
